These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19959252)

  • 1. An investigation on electronic nose diagnosis of lung cancer.
    D'Amico A; Pennazza G; Santonico M; Martinelli E; Roscioni C; Galluccio G; Paolesse R; Di Natale C
    Lung Cancer; 2010 May; 68(2):170-6. PubMed ID: 19959252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smells like cancer.
    Horvath I
    Lung Cancer; 2010 May; 68(2):127-8. PubMed ID: 20227131
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenic markers in breath condensate identify non-small cell lung cancer.
    Gessner C; Rechner B; Hammerschmidt S; Kuhn H; Hoheisel G; Sack U; Ruschpler P; Wirtz H
    Lung Cancer; 2010 May; 68(2):177-84. PubMed ID: 19647334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
    Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
    Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of melanoma with a gas sensor array.
    D'Amico A; Bono R; Pennazza G; Santonico M; Mantini G; Bernabei M; Zarlenga M; Roscioni C; Martinelli E; Paolesse R; Di Natale C
    Skin Res Technol; 2008 May; 14(2):226-36. PubMed ID: 18412567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers.
    McCulloch M; Jezierski T; Broffman M; Hubbard A; Turner K; Janecki T
    Integr Cancer Ther; 2006 Mar; 5(1):30-9. PubMed ID: 16484712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
    Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E
    Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry.
    Deng C; Zhang X; Li N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):269-77. PubMed ID: 15261821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled breath analysis: novel approach for early detection of lung cancer.
    Chan HP; Lewis C; Thomas PS
    Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
    Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
    Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cheek swab technique may detect lung cancer.
    Printz C
    Cancer; 2011 Mar; 117(5):881-91. PubMed ID: 21351081
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung cancer biomarkers in exhaled breath.
    Amann A; Corradi M; Mazzone P; Mutti A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
    BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.